Yisheng Biopharma focuses on innovative biopharmaceutical technologies, particularly in the development of novel vaccines and therapeutics. The company employs advanced platform technologies that leverage its expertise in recombinant protein expression and purification. This allows Yisheng to create effective vaccine candidates and therapeutic proteins that target various diseases, including infectious diseases and cancers. Their pipeline includes several promising candidates that are in various stages of clinical development, showcasing the company's commitment to addressing unmet medical needs through cutting-edge science.

In addition to vaccine development, Yisheng Biopharma utilizes proprietary technologies for the formulation and delivery of biologics. This includes the use of adjuvants to enhance immune responses and improve the efficacy of their vaccine candidates. The company emphasizes a strong scientific foundation, with a focus on research and development to drive innovation in the biopharmaceutical sector. By integrating their technological capabilities with rigorous scientific research, Yisheng Biopharma aims to bring transformative therapies to market that can significantly impact patient health outcomes.

China

Yisheng Biopharma is a global biopharmaceutical company with fully integrated research, manufacturing and commercialization capabilities developing innovative biotherapeutics for cancers and infectious diseases.

LakeShore Biopharma Co., Ltd (Previously Yisheng Bio)

Company Details